RPBC Financials 07/15/2014 23:40:44
Redpoint Bio Corp.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 525 1,244
Cost of Revenue - -
Gross Profit 525 1,244
Operating Expenses
Research and Development 1,021 3,042
Sales, General and Admin. 1,937 3,644
Non-Recurring Items - -
Other - -
Operating Income (2,433) (5,441)
Income From Continuing Operations
Add'l Income/Expense Items 1,617 11
Earnings Before Interest and Tax (816) (5,430)
Interest Expense 35 141
Earnings Before Tax (851) (5,571)
Income Tax (411) (101)
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (440) (5,470)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (440) (5,470)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (440) (5,470)